Gershey, E. L., Vidali, G. & Allfrey, V. G. Chemical studies of histone acetylation. The occurrence of epsilon-N-acetyllysine in the f2a1 histone. J. Biol. Chem. 243, 5018–5022 (1968).
Article CAS PubMed Google Scholar
Ali, I., Conrad, R. J., Verdin, E. & Ott, M. Lysine acetylation goes global: from epigenetics to metabolism and therapeutics. Chem. Rev. 118, 1216–1252 (2018).
Article CAS PubMed PubMed Central Google Scholar
Zhou, K., Gaullier, G. & Luger, K. Nucleosome structure and dynamics are coming of age. Nat. Struct. Mol. Biol. 26, 3–13 (2019).
Article CAS PubMed Google Scholar
Wang, Z. A. & Cole, P. A. The chemical biology of reversible lysine post-translational modifications. Cell Chem. Biol. 27, 953–969 (2020).
Article PubMed PubMed Central Google Scholar
Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).
Article CAS PubMed Google Scholar
Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487–500 (2016).
Article CAS PubMed Google Scholar
Lee, K. et al. Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1. Nat. Chem. Biol. https://doi.org/10.1038/s41589-024-01671-9 (2024).
Article PubMed PubMed Central Google Scholar
Zaware, N. & Zhou, M. M. Bromodomain biology and drug discovery. Nat. Struct. Mol. Biol. 26, 870–879 (2019).
Article CAS PubMed PubMed Central Google Scholar
Paik, W. K., Pearson, D., Lee, H. W. & Kim, S. Nonenzymatic acetylation of histones with acetyl-CoA. Biochim. Biophys. Acta 213, 513–522 (1970).
Article CAS PubMed Google Scholar
Hansen, B. K. et al. Analysis of human acetylation stoichiometry defines mechanistic constraints on protein regulation. Nat. Commun. 10, 1055 (2019).
Article PubMed PubMed Central Google Scholar
Mascarenhas, J. et al. MANIFEST: pelabresib in combination with ruxolitinib for Janus kinase inhibitor treatment-naive myelofibrosis. J. Clin. Oncol. 41, 4993–5004 (2023).
Article CAS PubMed PubMed Central Google Scholar
Gupta, V. et al. Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis. Blood Adv. 7, 5421–5432 (2023).
Article CAS PubMed PubMed Central Google Scholar
Mukohara, T. et al. Inhibition of lysine acetyltransferase KAT6 in ER+HER2– metastatic breast cancer: a phase 1 trial. Nat. Med. 30, 2242–2250 (2024).
Article CAS PubMed PubMed Central Google Scholar
Kleff, S., Andrulis, E. D., Anderson, C. W. & Sternglanz, R. Identification of a gene encoding a yeast histone H4 acetyltransferase. J. Biol. Chem. 270, 24674–24677 (1995).
Article CAS PubMed Google Scholar
Brownell, J. E. et al. Tetrahymena histone acetyltransferase A: a homolog of yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843–851 (1996).
Article CAS PubMed Google Scholar
Roth, S. Y., Denu, J. M. & Allis, C. D. Histone acetyltransferases. Annu. Rev. Biochem. 70, 81–120 (2001).
Article CAS PubMed Google Scholar
Whedon, S. D. & Cole, P. A. KATs off: Biomedical insights from lysine acetyltransferase inhibitors. Curr. Opin. Chem. Biol. 72, 102255 (2023).
Article CAS PubMed Google Scholar
Baeza, J., Smallegan, M. J. & Denu, J. M. Mechanisms and dynamics of protein acetylation in mitochondria. Trends Biochem. Sci. 41, 231–244 (2016).
Article CAS PubMed PubMed Central Google Scholar
Marmorstein, R. & Zhou, M. M. Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harb. Perspect. Biol. 6, a018762 (2014).
Article PubMed PubMed Central Google Scholar
Taylor, S. S., Zhang, P., Steichen, J. M., Keshwani, M. M. & Kornev, A. P. PKA: lessons learned after twenty years. Biochim. Biophys. Acta 1834, 1271–1278 (2013).
Article CAS PubMed PubMed Central Google Scholar
Dancy, B. M. & Cole, P. A. Protein lysine acetylation by p300/CBP. Chem. Rev. 115, 2419–2452 (2015).
Article CAS PubMed PubMed Central Google Scholar
Xu, L. et al. TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition. Nat. Commun. 14, 5362 (2023).
Article CAS PubMed PubMed Central Google Scholar
Ghandi, M. et al. Next-generation characterization of the cancer cell line encyclopedia. Nature 569, 503–508 (2019).
Article CAS PubMed PubMed Central Google Scholar
Kumar, M. et al. Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Nat. Commun. 12, 6340 (2021).
Article CAS PubMed PubMed Central Google Scholar
Zhang, Y. et al. Nuclear condensates of p300 formed though the structured catalytic core can act as a storage pool of p300 with reduced HAT activity. Nat. Commun. 12, 4618 (2021).
Article CAS PubMed PubMed Central Google Scholar
Gibson, B. A. et al. Organization of chromatin by intrinsic and regulated phase separation. Cell 179, 470–484.e21 (2019).
Article CAS PubMed PubMed Central Google Scholar
Dancy, B. M. & Cole, P. A. Correction to protein lysine acetylation by p300/CBP. Chem. Rev. 116, 8314 (2016).
Article CAS PubMed PubMed Central Google Scholar
Narita, T. et al. Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes. Nat. Genet. 55, 679–692 (2023).
Article CAS PubMed PubMed Central Google Scholar
Kikuchi, M. et al. Epigenetic mechanisms to propagate histone acetylation by p300/CBP. Nat. Commun. 14, 4103 (2023).
Article CAS PubMed PubMed Central Google Scholar
Tang, Y. et al. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat. Struct. Mol. Biol. 15, 738–745 (2008).
Comments (0)